Teligent (TLGT)
(Real Time Quote from BATS)
$0.17 USD
0.00 (-2.02%)
Updated Oct 15, 2021 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Teligent, Inc. [TLGT]
Reports for Purchase
Showing records 1 - 20 ( 53 total )
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
We are dropping coverage to reallocate our research resources
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
2Q19 Recap Strong Quarter; Covenant Risk Declining
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
2Q18 Recap - Noisy, but Fundamentals Intact and Improving
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Teligent, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.